Effect of furosemide on the lipid abnormalities in chronic renal failure.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Acta Medica Scandinavica

• Publication date

  2009-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.0954-6820.1983.TB08587.XPMID 6624545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.

  2009cited by this paper
• Hypertriglyceridemia.

  2006cited by this paper
• Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol.

  1982cited by this paper
• Serum lipoproteins in chronic renal failure.

  1981cited by this paper
• Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial.

  1981cited by this paper
• The effect of chlorthalidone on serum lipids and lipoproteins.

  1980cited by this paper
• Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone.

  1980cited by this paper
• [Secondary hyperlipoproteinemia induced by diuretic therapy (author's transl)].

  1980cited by this paper
• Effects of diuretics on plasma lipoproteins in healthy men

  1980cited by this paper
• Droughts and diarrhoea.

  1980cited by this paper
• Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension.

  1979cited by this paper
• Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension

  1979cited by this paper
• Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.

  1978cited by this paper
• Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect?

  1978cited by this paper
• Raised serum lipid concentrations during diuretic treatment of hypertension: a study of predictive indexes.

  1978cited by this paper
• Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein.

  1978cited by this paper
• Elevation of serum lipid levels during diuretic therapy of hypertension.

  1976cited by this paper
• Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.

  1976cited by this paper
• Increase in serum-lipids during treatment of hypertension with chlorthalidone.

  1976cited by this paper
• Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation.

  1975cited by this paper
• An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma.

  1975cited by this paper
• ENDOCRINOLOGY AND METABOLISM IN UREMIA AND DIALYSIS: A CLINICAL REVIEW

  1975cited by this paper
• Radioimmunoassays employing immunosorbents.

  1969cited by this paper
• Triple-tracer technique for measuring red-blood-cell, plasma and extracellular-fluid volume.

  1968cited by this paper
• Hypertriglyceridemia. A metabolic consequence of chronic renal failure.

  1968cited by this paper

• Influence of L-Carnitine Supplementation on Serum Lipid Profile in Hemodialysis Patients: A Systematic Review and Meta-Analysis

  2014cites this paper
• Use of diuretics in chronic renal failure.

  1997cites this paper
• Indications for the Use of Diuretics in Patients with Renal Impairment

  1997cites this paper
• Hypercholesterolaemia and vascular disease after transplantation

  1991cites this paper
• The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.

  1990cites this paper
• Central nervous system considerations in the use of beta-blockers, angiotensin-converting enzyme inhibitors, and thiazide diuretics in managing essential hypertension.

  1988cites this paper
• Effect of diabetes mellitus and end-stage renal disease on HDL metabolism.

  1986cites this paper
• Clinical efficacy and safety of long-term diuretic treatment in renal parenchymal hypertension.

  1985cites this paper